Real life outcomes matter – Breaking DEM-TACE news from ESMO GI
Join this online webcast covering more than 550 patients data from EMSO GI. We aim to give DEM-TACE a stronger voice in tumour board discussions by sharing real world data and the latest news on LifePearlTM microspheres.
Pick your time!
This webinar will be broadcasted live twice, register now for one of them:
Pick the time that suits you the most!
- Share the latest news from ESMO-GI about real world clinical outcomes of >550 HCC patients treated with DEM-TACE
- Discuss the impact of big data from liver directed therapies to the multidisciplinary tumour board decision making process
- Explore DEM-TACE current practice and performance in various subsets of patients